Background. Twenty-nine patients with metastatic renal cell carcinoma (RCC) were treated with constantinfusion floxuridine (FUdR, Roche Laboratories, Nut-Methods. The initial dosage was 0.075 mg/kg/day for 14 days every 28 days and was increased or decreased by 0.025-mg/kg/day increments at each sub
โฆ LIBER โฆ
Aerosol BCG treatment of carcinoma metastatic to the lung: A phase I study
โ Scribed by Fredric B. Garner; Carol A. Meyer; Deborah S. White; Allan Lipton
- Publisher
- John Wiley and Sons
- Year
- 1975
- Tongue
- English
- Weight
- 495 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
A phase II study of constant-infusion fl
โ
Mary J. Wilkinson; John W. Frye; Eric J. Small; Alan P. Venook; Peter R. Carroll
๐
Article
๐
1993
๐
John Wiley and Sons
๐
English
โ 347 KB
๐ 2 views
Phase II study of paclitaxel and epirubi
โ
Giovanni L. Ceresoli; Stefania Dell'Oro; Paolo Passoni; Eugenio Villa
๐
Article
๐
2000
๐
John Wiley and Sons
๐
English
โ 90 KB
๐ 2 views
A phase II study of the combination of c
โ
T. Le Chevalier; F. Thomas; R. Subirana; P. Baldeyrou; P. Ruffie; T. Tursz; R. A
๐
Article
๐
1991
๐
John Wiley and Sons
๐
English
โ 317 KB
๐ 2 views
Phase II trial of chemoembolization for
โ
Claudia Tellez; Al B. Benson III; Michael T. Lyster; Mark Talamonti; John Shaw;
๐
Article
๐
1998
๐
John Wiley and Sons
๐
English
โ 130 KB
๐ 1 views
an injection of a bovine collagen material with cisplatin (10 mg/mL), doxorubicin (3 mg/mL), and mitomycin C (3 mg/mL). Repeat treatments were performed at
Phase II study of patients with metastat
โ
William J. Tester; Pamela Y. Jin; Deborah H. Reardon; Jeffrey B. Cohn; Martin H.
๐
Article
๐
1997
๐
John Wiley and Sons
๐
English
โ 77 KB
๐ 2 views
## METHODS. Twenty patients with histologically proven Stage IV NSCLC were en-Pennsylvania. rolled in this study. All were treated on an outpatient basis with standard premedication followed by paclitaxel 200 mg/m 2 infused intravenously over 3 hours. Treatments were repeated every 21 days for a
A phase II study of gemcitabine plus ora
โ
Tony S. K. Mok; Benny Zee; Anthony T. C. Chan; Winnie Yeo; Wei Tse Yang; Anthony
๐
Article
๐
2000
๐
John Wiley and Sons
๐
English
โ 95 KB
๐ 2 views